Figure 1From: Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease Individual IBD patients with chronic active disease refractory to conventional medications. Patients in clinical and endoscopic remission secondary to selective apheresis treatment. Follow-up time in months.Back to article page